Document is current
Any future updates will be listed below
-
Authors
Heppt, Markus V.
Trin, Kilian
Mille, Anne-Cécile
Groc, Mélanie
Delarue, Alain
Bégeault, Nathalie https://orcid.org/0009-0004-6854-9996
- License Information
-
More Information
Article History
Received: 15 October 2024
Accepted: 23 December 2024
First Online: 16 January 2025
Declarations
:
: Markus V. Heppt has received honoraria from MSD, BMS, Roche, Novartis, Sun Pharma, Sanofi, Almirall, Biofrontera, Galderma, Immuncore, Pierre Fabre and InfectoPharm. Kilian Trin, and Alain Delarue worked in Pierre Fabre Laboratories at the time of the study. Mélanie Groc and Nathalie Bégeault are employees of Pierre Fabre. Anne-Cécile Mille is an employee of Atlanstat.
: This pooled analysis was based on previously conducted studies and does not contain any direct investigation with human participants or animals performed by any of the authors. Studies HD-FUP3B-048 and HD-FUP3B-049 received ethical approval from the institutional review boards of all relevant study sites and were conducted in compliance with US Food and Drug Administration regulations, the ethical principles of the Declaration of Helsinki, and the current International Conference on Harmonisation Good Clinical Practice guidelines. Patients provided written informed consent to participate in the studies.
